Literature DB >> 30289957

Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased Vigilance.

Jerry H Gurwitz1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30289957      PMCID： PMC6235709          DOI： 10.1111/jgs.15561

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  2 in total

1.  FDA Approval of Desmopressin for Nocturia.

Authors:  Michael Fralick; Aaron S Kesselheim
Journal:  JAMA       Date:  2017-05-23       Impact factor: 56.272

2.  Nocturia and disturbed sleep in the elderly.

Authors:  Donald L Bliwise; Daniel J Foley; Michael V Vitiello; Farzaneh Pour Ansari; Sonia Ancoli-Israel; James K Walsh
Journal:  Sleep Med       Date:  2008-08-13       Impact factor: 3.492
  2 in total
  1 in total

1.  Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.

Authors:  Kara Suvada; Laura Plantinga; Camille P Vaughan; Alayne D Markland; Anna Mirk; Kathryn L Burgio; Susanne M Erni; Mohammed K Ali; Ike Okosun; Henry Young; Patricia S Goode; Theodore M Johnson
Journal:  Clin Ther       Date:  2020-11-28       Impact factor: 3.393
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.